Walleye Capital LLC Catalent, Inc. Put Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $532,000 - $747,750	-12,500 Reduced 79.11%	3,300 $186,000
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $363,634 - $526,241	11,300 Added 251.11%	15,800 $709,000
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $163,540 - $185,740	3,700 Added 462.5%	4,500 $204,000
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $3,186 - $6,726	100 Added 14.29%	800 $34,000
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $31,808 - $51,982	700 New	700 $45,000

365

138M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.